Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: Relationship with response to therapy and survival

Cancer Immunology Immunotherapy

Volumn 49, Issue 10, 2000, Pages 530-536

  Orditura, Michele ^a   Romano, Ciro ^a   De Vita, Ferdinando ^a   Galizia, Gennaro ^a   Lieto, Eva ^a   Infusino, Stefania ^a   De Cataldis, Giuseppe ^b   Catalano, Giuseppe ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Daprocida Hospital   (Italy)

Author keywords

IL 2 serum levels; NSCLC; Prognosis

Indexed keywords

CISPLATIN; ETOPOSIDE; INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; IMMUNE RESPONSE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TH1 CELL; TREATMENT OUTCOME;

EID: 0033653516     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620000150     Document Type: Article

References (22)

1. DNA damage and repair in human lymphocytes exposed to three anticancer platinum drugs
2. The host-tumor immune conflict: From immunosuppression to resistance and destruction
3. Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients
4. Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung mestastases
5. Effect of local interleukin-2 treatment on spontaneous tumours of different immunogenic strength
6. Increased interleukin-10 serum levels in patients with solid tumors
7. Interleukin-2 gene transduction into freshly isolated lung adenocarcinoma cells with adenoviral vectors
8. Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma
9. IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile
10. Human non-small cell lung cancer express a type 2 cytokine pattern
11. Tumour-infiltrating lymphocytes in non-small cell lung cancer are activated T lymphocytes
12. T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanomas
13. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
14. Immunosuppressive cytokines (IL-10, TGF-beta) gene expression in human gastric carcinoma tissues
15. Depression of NK cytotoxic activity in lymphocytes infiltrating human pulmonary tumors
16. The role of cytokines in cancer
17. Lymphokine production by human T cells in disease states
18. On the relative roles of interleukin-2 and interleukin-10 in the -generation of lymphokine-activated killer cell activity
19. Cytokine production by human soft tissue sarcomas: Implications for immunosuppression within the turnout bed
20. Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells
21. Effects of immunization with tumor cells double transfected with interleukin-2 (IL-2) and interleukin-12 (IL-12) genes on artificial metastasis of colon26 cells in BALB/c mice
22. High incidence of interleukin 10 mRNA but not interleukin-2 mRNA detected in human breast tumours